Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
1(10%)
Results Posted
33%(2 trials)

Phase Distribution

Ph not_applicable
1
10%
Ph phase_1
2
20%
Ph phase_2
1
10%
Ph phase_3
1
10%
Ph phase_4
5
50%

Phase Distribution

2

Early Stage

1

Mid Stage

6

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
2(20.0%)
Phase 2Efficacy & side effects
1(10.0%)
Phase 3Large-scale testing
1(10.0%)
Phase 4Post-market surveillance
5(50.0%)
N/ANon-phased studies
1(10.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(2)
Completed(6)
Other(2)

Detailed Status

Completed6
unknown2
Recruiting1
Enrolling by invitation1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (20.0%)
Phase 21 (10.0%)
Phase 31 (10.0%)
Phase 45 (50.0%)
N/A1 (10.0%)

Trials by Status

completed660%
recruiting110%
enrolling_by_invitation110%
unknown220%

Recent Activity

Clinical Trials (10)

Drug Details

Intervention Type
DRUG
Total Trials
10